-transparent.png){kind=logo}
OBJECTIVE The purpose of the present study was to evaluate plasma glucagon-like peptide-1 (GLP-1) responses after oral glucose ingestion in patients with chronic pancreatitis and to clarify how GLP-1 secretion relates to pancreatic diabetes. METHODS An oral glucose tolerance test (OGTT) was performed in 17 patients with chronic pancreatitis. Plasma glucose, immunoreactive insulin (IRI), C-peptide, glucagon, and GLP-1 levels at each time point during OGTT were measured. The diagnosis of chronic pancreatitis was made by the findings of endoscopic retrograde pancreatography (ERP): evident dilation of the main pancreatic duct with or without pancreatolithiasis. RESULTS The patients were divided into three groups according to the World Health Organization classification of diabetes based on plasma glucose levels after OGTT. The groups were: normal (three patients), impaired glucose tolerant (IGT) (six patients), and diabetic (DM) (eight patients). In the DM group, IRI and C-peptide response levels after oral glucose ingestion were significantly reduced as compared with those of the normal and IGT groups. No significant glucagon responses to oral glucose ingestion were found in the three groups. In contrast, plasma GLP-1 levels were significantly elevated after oral glucose ingestion in the DM groups as compared with normal and IGT groups. CONCLUSIONS The present study affords evidence that plasma GLP-1 levels become elevated with development of pancreatic diabetes, although the precise mechanism of this elevation remains undetermined.
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
April 1995,
Hepatology (Baltimore, Md.),
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
April 2008,
Trends in molecular medicine,
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
October 2007,
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi,
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
April 2009,
American journal of physiology. Endocrinology and metabolism,
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
January 2018,
Digestion,
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
March 2004,
Critical care medicine,
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
May 2022,
Diabetes, obesity & metabolism,
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
January 2005,
Clinical endocrinology,
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
September 2014,
Food & function,
M Hiroyoshi, and
K Tateishi, and
Y Yasunami, and
K Maeshiro, and
J Ono, and
Y Matsuoka, and
S Ikeda
January 2015,
PloS one,
